National Institute Of Blood Disease and Bone Marrow Transplantation

Recent papers from National Institute Of Blood Disease and Bone Marrow Transplantation

1. Pilot Testing for Knowledge, Attitudes, and Practices (KAP) Survey on Cumulative Antibiogram Use Among Healthcare Professionals Managing Immunocompromised ChildrenJournal of the Pediatric Infectious Diseases Society · 2026
2. Hepatobiliary complications in Immune thrombocytopenic purpura; Pouring more diesel to igniting fireHaematology Journal of Bangladesh · 2026
3. Clinical outcomes of ASCT in multiple myeloma: a study of the Plasma Cell Dyscrasia Working Party of PBMTBlood Global Hematology · 2026
4. Cancer Prevalence Trends in Kyrgyzstan (2020-2026): A Population-Based Epidemiologic AnalysisJCO Global Oncology · 2026
5. RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-HFrontiers in Medicine · 2026
6. A Site-Specific LLM-Based PHI Redaction Tool to Support Note De-Identification for the United States Immunodeficiency Network (USIDNET)SHILAP Revista de lepidopterología · 2026
7. Impact of Pre‐Transplant Depth of Response on Outcomes in Patients With Multiple Myeloma: A Report on Behalf of Pakistan Blood and Marrow Transplant GroupAsia-Pacific Journal of Clinical Oncology · 2026
8. Celebrating the evolution of bone marrow transplantCancer Nursing Practice · 2026
9. Early Outcomes of Pretransplant Immunosuppression (PTIS) Based Conditioning Regimen in Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)Transplantation and Cellular Therapy · 2026
10. Experiences with real-world teclistamab administration in community and outpatient settings: a mixed-methods study of hematology providersCurrent Medical Research and Opinion · 2026
11. Hypomethylating Agents and Venetoclax Based Triplets Targeting FLT3, IDH and KMT2A in Acute Myeloid Leukemia: Current Studies and Challenges of a Tailored ApproachCancers · 2026
12. Advancing multiple myeloma therapy: A systematic analysis of corticosteroids and monoclonal antibodies as dual therapeutic agentsWorld Journal of Methodology · 2026
13. From Concept to Implementation: Clinical Utilization of Mentzer Score as A Screening Tool for the Differentiation of Iron Deficiency Anaemia and Beta Thalassemia TraitHaematology Journal of Bangladesh · 2026
14. Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA RegistryAmerican Journal of Hematology · 2025
15. Intra-host diversity of SARS-CoV-2 in children with long-term and short-term excretion in nasopharyngeal samplesBMC Infectious Diseases · 2025
16. Germline predisposition to acute myeloid leukemia in polish patientsLeukemia & lymphoma/Leukemia and lymphoma · 2025
17. Circulating Erythrocyte‐ and Endothelial‐Derived Microvesicles as Biomarkers of Hemolysis and Clinical Severity in Sickle Cell DiseaseJournal of Cellular and Molecular Medicine · 2025
18. Molecular landscape of non-driver genes in myeloproliferative neoplasms through 333 cancer genes panel: Insights to reveal in PakistanBMC Medical Genomics · 2025
19. Evaluation of hepatotoxicity due to conditioning regimens in beta thalassemia major and aplastic anemia patients undergoing bone marrow transplantationJournal of Oncology Pharmacy Practice · 2025
20. Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplantJCI Insight · 2025